Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0031 | 0.0404 | 0.1549 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0031 | 0.0404 | 0.1549 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0039 | 0.0698 | 1 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0031 | 0.0404 | 0.1537 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0031 | 0.0404 | 0.5 |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.0039 | 0.0698 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0031 | 0.0404 | 0.1549 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0064 | 0.164 | 0.164 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.164 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0204 | 0.6921 | 0.8898 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0227 | 0.7779 | 1 |
Loa Loa (eye worm) | inositol-1 | 0.0039 | 0.0698 | 0.268 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.164 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0204 | 0.6921 | 0.8898 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0039 | 0.0698 | 0.268 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0031 | 0.0404 | 0.0519 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0031 | 0.0404 | 0.0404 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0031 | 0.0404 | 0.1549 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0064 | 0.164 | 0.6246 |
Schistosoma mansoni | inositol monophosphatase | 0.0039 | 0.0698 | 0.0698 |
Treponema pallidum | NADH oxidase | 0.0031 | 0.0404 | 0.5 |
Brugia malayi | glutathione reductase | 0.0089 | 0.2605 | 1 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0031 | 0.0404 | 0.1549 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0031 | 0.0404 | 0.1549 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0039 | 0.0698 | 0.268 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.0039 | 0.0698 | 0.2659 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.164 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0023 | 0.0094 | 0.036 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0227 | 0.7779 | 1 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0039 | 0.0698 | 0.1338 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0031 | 0.0404 | 0.1549 |
Brugia malayi | Inositol-1 | 0.0039 | 0.0698 | 0.268 |
Toxoplasma gondii | thioredoxin reductase | 0.0089 | 0.2605 | 1 |
Leishmania major | trypanothione reductase | 0.0089 | 0.2605 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0031 | 0.0404 | 0.1549 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0089 | 0.2605 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0064 | 0.164 | 0.2108 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0204 | 0.6921 | 0.8898 |
Plasmodium falciparum | thioredoxin reductase | 0.0089 | 0.2605 | 1 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0031 | 0.0404 | 0.1549 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0204 | 0.6921 | 0.8814 |
Loa Loa (eye worm) | glutathione reductase | 0.0089 | 0.2605 | 1 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0031 | 0.0404 | 0.1549 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0227 | 0.7779 | 1 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0039 | 0.0698 | 0.268 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0035 | 0.0545 | 0.07 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0023 | 0.0094 | 0.036 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0039 | 0.0698 | 0.268 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0204 | 0.6921 | 0.8898 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0031 | 0.0404 | 0.1549 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0039 | 0.0698 | 0.4258 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0031 | 0.0404 | 0.1549 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0089 | 0.2605 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0089 | 0.2605 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0064 | 0.164 | 0.5614 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0031 | 0.0404 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0064 | 0.164 | 0.164 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0204 | 0.6921 | 0.8898 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0089 | 0.2605 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0064 | 0.164 | 0.6294 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.009 | 0.2625 | 1 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0039 | 0.0698 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0089 | 0.2605 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0089 | 0.2605 | 0.3349 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0031 | 0.0404 | 0.5781 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0031 | 0.0404 | 0.1537 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0031 | 0.0404 | 0.1549 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0031 | 0.0404 | 0.5781 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0031 | 0.0404 | 0.2461 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0039 | 0.0698 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0064 | 0.164 | 0.6246 |
Schistosoma mansoni | inositol monophosphatase | 0.0039 | 0.0698 | 0.0698 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0039 | 0.0698 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0089 | 0.2605 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0031 | 0.0404 | 0.1549 |
Brugia malayi | Thioredoxin reductase | 0.0089 | 0.2605 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.009 | 0.2625 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0031 | 0.0404 | 0.1549 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0031 | 0.0404 | 0.2461 |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.0039 | 0.0698 | 0.2659 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0031 | 0.0404 | 0.1549 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0031 | 0.0404 | 0.1549 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0031 | 0.0404 | 0.2461 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0227 | 0.7779 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0204 | 0.6921 | 0.8898 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0031 | 0.0404 | 0.1549 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | 0 % | Inhibition of Angiotensin I converting enzyme from rabbit lung acetone powder extract; Inactive | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.